Effects of calcium supplementation on bone loss and fractures in congestive heart failure

European Journal of Endocrinology

Volumn 156, Issue 3, 2007, Pages 309-314

  Frost, Robert J A ^a   Sonne, Carolin ^a   Wehr, Uli ^a   Stempfle, Hans Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CREATININE; ESTRADIOL; LOOP DIURETIC AGENT; MAGNESIUM; PHOSPHATE; TESTOSTERONE; THIAZIDE DIURETIC AGENT; WARFARIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMUR NECK; FRAGILITY FRACTURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERPARATHYROIDISM; HYPOGONADISM; KIDNEY DYSFUNCTION; LUMBAR SPINE; MAGNESIUM BLOOD LEVEL; MALE; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AMINO ACIDS; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM, DIETARY; CREATININE; DENSITOMETRY, X-RAY; FRACTURES, BONE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34147117848     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-06-0614     Document Type: Article

References (25)

1. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM & Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005. Journal of Heart and Lung Transplantation 2005 24 956-967.
2. Rodino MA & Shane E. Osteoporosis after organ transplantation. American Journal of Medicine 1998 104 459-469.
3. Stempfle HU, Werner C, Siebert U, Assum T, Wehr U, Rambeck WA, Meiser B, Theisen K & Gartner R. The role of tacrolimus (FK506)- based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 2002 73 547-552.
4. Sambrook PN, Kelly PJ, Keogh AM, Macdonald P, Spratt P, Freund J & Eisman JA. Bone loss after heart transplantation: A prospective study. Journal of Heart and Lung Transplantation 1994 13 116-121.
5. Stempfle HU, Werner C, Echtler S, Wehr U, Rambeck WA, Siebert U, Uberfuhr P, Angermann CE, Theisen K & Gartner R. Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 1999 68 523-530.
6. Christ E, Linka A, Junga G, Odermatt M, Steinert H, Kiowski W & Schmid C. Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease. Schweizerische Medizinische Wochenschrift 1996 126 1553-1559.
7. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V & McMahon DJ. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. American Journal of Medicine 1997 103 197-207.
8. Lee AH, Mull RL, Keenan GF, Callegari PE, Dalinka MK, Eisen HJ, Mancini DM, DiSesa VJ & Attie MF. Osteoporosis and bone morbidity in cardiac transplant recipients. American Journal of Medicine 1994 96 35-41.
9. Kerschan-Schindl K, Strametz-Juranek J, Heinze G, Grampp S, Bieglmayer C, Pacher R, Maurer G, Fialka-Moser V & Pietschmann P. Pathogenesis of bone loss in heart transplant candidates and recipients. Journal of Heart and Lung Transplantation 2003 22 843-850.
10. Shane E, Rivas M, Staron RB, Silverberg SJ, Seibel MJ, Kuiper J, Mancini D, Addesso V, Michler RE & Factor-Litvak P. Fracture after cardiac transplantation: a prospective longitudinal study. Journal of Clinical Endocrinolology and Metabolism 1996 81 1740-1746.
11. Nishio K, Mukae S, Aoki S, Itoh S, Konno N, Ozawa K, Satoh R & Katagiri T. Congestive heart failure is associated with the rate of bone loss. Journal of Internal Medicine 2003 253 439-446.
12. Reid IR, Ames RW, Evans MC, Gamble GD & Sharpe SJ. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. American Journal of Medicine 1995 98 331-335.
13. Muchmore JS, Cooper DK, Ye Y, Schlegel V, Pribil A & Zuhdi N. Prevention of loss of vertebral bone density in heart transplant patients. Journal of Heart and Lung Transplantation 1992 11 959-963.
14. Shane E, Rivas M, McMahon DJ, Staron RB, Silverberg SJ, Seibel MJ, Mancini D, Michler RE, Aaronson K, Addesso V & Lo SH. Bone loss and turnover after cardiac transplantation. Journal of Clinical Endocrinolology and Metabolism 1997 82 1497-1506.
15. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth CA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M & Thygesen K. ESC Committe for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. European Heart Journal 2005 26 384-416.
16. Kanis JA, Melton LJ, Christiansen C, Johnston CC & Khaltaev N. The diagnosis of osteoporosis. Journal of Bone Mineral Research 1994 9 1137.
17. Eastell R, Cedel SL, Wahner HW Riggs BI & Melton LJ III. Classification of vertebral fractures. Journal of Bone Mineral Research 1991 6 207.
18. Reichel H, Deibert B, Schmidt-Gayk H & Ritz E. Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism. Nephrology, Dialysis and Transplantation 1991 6 162-169.
19. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F & Mosekilde L. Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study. Journal of internal Medicine 2001 250 144-153.
20. Kaufman JM & Vermeulen A. Androgens in male senescence. In Testosterone: action, deficiency, substitution, edn 2, pp 437-472. Eds E Nieschlag & HM Behre. Heidelberg: Springer, 1998.
21. Kontoleon PE, Anastasiou-Nana MI, Papapetrou PD, Alexopoulos G, Ktenas V, Rapti AC, Tsagalou EP & Nanas JN. Hormonal profile in patients with congestive heart failure. International Journal of Cardiology 2003 87 179-183.
22. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxineyer H & Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992 257 88-91.
23. Orimo H, Fujita T & Yoshikawa M. Increased sensitivity of bone to parathyroid hormone in ovariectornized rats. Endocrinology 1972 90 760-763.
24. Malkin CJ, Pugh PJ, West JN, van Beek EJ, Jones TH & Channer KS. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. European Heart Journal 2006 27 57-64.
25. Philip WJ, Martin JC, Richardson JM, Reid DM, Webster J & Douglas AS. Decreased axial and peripheral bone density in patients taking longterm warfarin. Quarterly Journal of Medicine 1995 88 635-640.